Last reviewed · How we verify

2011-2012 seasonal flu vaccine Subcutaneous

Children's Hospital Medical Center, Cincinnati · FDA-approved active Biologic Quality 2/100

2011-2012 seasonal flu vaccine Subcutaneous is a Biologic drug developed by Children's Hospital Medical Center, Cincinnati. It is currently FDA-approved. Also known as: fluzone.

At a glance

Generic name2011-2012 seasonal flu vaccine Subcutaneous
Also known asfluzone
SponsorChildren's Hospital Medical Center, Cincinnati
ModalityBiologic
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about 2011-2012 seasonal flu vaccine Subcutaneous

What is 2011-2012 seasonal flu vaccine Subcutaneous?

2011-2012 seasonal flu vaccine Subcutaneous is a Biologic drug developed by Children's Hospital Medical Center, Cincinnati.

Who makes 2011-2012 seasonal flu vaccine Subcutaneous?

2011-2012 seasonal flu vaccine Subcutaneous is developed and marketed by Children's Hospital Medical Center, Cincinnati (see full Children's Hospital Medical Center, Cincinnati pipeline at /company/children-s-hospital-medical-center-cincinnati).

Is 2011-2012 seasonal flu vaccine Subcutaneous also known as anything else?

2011-2012 seasonal flu vaccine Subcutaneous is also known as fluzone.

What development phase is 2011-2012 seasonal flu vaccine Subcutaneous in?

2011-2012 seasonal flu vaccine Subcutaneous is FDA-approved (marketed).

Related